Published January 11, 2020 | Version v1
Journal article Open

Use of the complex of models of regression for analysis of the factors that determine the severity of bronchial asthma

Authors/Creators

  • 1. National Technical University "Kharkov Polytechnic Institute"
  • 2. Kharkiv National Medical University

Description

Background: According to an International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence of asthma in children of 6-7 years old has increased by 10%, and at the age of 13-14 years by 16% over the last decade. Determining the factors that are keys to the occurrence of the disease and its severity is important in explaining the pathogenesis of bronchial asthma. 
Methods: Analyzed 142 indicators of clinical and paraclinical examination of 70 children with asthma. To select factors that could be significant in the formation of severe asthma, applied the method of logistic regression with step-by-step inclusion of predictors. Both quantitative and qualitative characteristics were selected. Each qualitative attribute was coded “1” if the child had this characteristic, or “0” if this characteristic had not been established. The formation of a severe asthma course was accepted according to (1) and the absence of a severe asthma flow formation as (0).  
Results: Analyzed the model of paired regression, the boundary value of thymic stromal lymphopoietin was established, exceeding which indicates the high probability of the presence of severe bronchial asthma. Increasing the value of thymic stromal lymphopoietin by 10 pg/mL suggests an increase in the likelihood of severe asthma by 10%. 

Conclusions:  A  complex of steam regression models has been developed to determine the factors characterizing the severity of bronchial asthma. The risk of developing severe bronchial asthma in children has been determined and 15 factors have been identified that affect severe asthma. 

Files

PiKo2020.pdf

Files (2.1 MB)

Name Size Download all
md5:a053dcda56a7406d118a0a6d036f3c33
2.1 MB Preview Download

Additional details

References

  • 1. The global asthma report 2018. Auckland: The Global Asthma Network; 2018 [cited 2019 Sep 17]. Available from: www.globalasthmanetwork.org.
  • 2. Winer RA, Qin X, Harrington T, Moorman J, Zahran H. Asthma incidence among children and adults: Findings from the Behavioral Risk Factor Surveillance System Asthma Call-back Survey—United States, 2006–2008. J Asthma 2012;49:16-22.
  • 3. Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet 2015;386(9998):1075-85.
  • 4. Fleming L, Murray C, Bansal A, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J 2015;46:1322-33.
  • 5. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2013;43:343-73.
  • 6. Foster JM, McDonald VM, Guo M, Reddel HK. "I have lost in every facet of my life": the hidden burden of severe asthma. Eur Respir J 2017;50:1700765.
  • 7. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care. J Allergy Clin Immunol 2015;135:299-310.
  • 8. Fitzpatrick AM, Teague WG, Meyers DA, Peters SP, Li X, Li H, et al. Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011;127:382-9.e13.
  • 9. Just J, Gouvis-Echraghi R, Rouve S, Wanin S, Moreau D, Annesi-Maesano I. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J 2012;40:55-60.
  • 10. Konradsen JR, Nordlund B, Lidegran M, Pedroletti C, Grönlund H, van Hage M, et al. Problematic severe asthma: A proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol 2010;22(1-Part-I):9-18.
  • 11. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007;204:253-8.
  • 12. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu Mr, Travis M, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001;167:336-43.
  • 13. Wiener N. The Extrapolation, Interpolation, and Smoothing of Stationary Time Series. Willey; 1949.
  • 14. Kozhyna OS, Pihnastyi OM. Statistical data of a clinical study of the severity of bronchial asthma in children of the Kharkov region, 2017. Mendeley Data 2019;2.
  • 15. Kozhyna OS, Pihnastyi OM. Data structure of clinical research. Human Health & Disease 2019;3:71- 9.
  • 16. Kozhyna OS, Pihnastyi OM. Covariance coefficients factors from a clinical study of the severity of bronchial asthma in children of the Kharkov region, 2017. Mendeley Data 2019;1.
  • 17. Braken MB, Belanger K, Kukson VO, Trichet E, Kristiani DS, Lederer BP. Genetic and perinatal risk factors for the occurrence and severity of asthma: a review and theoretical analysis. Epidemiol Rev 2002;24:176–89.
  • 18. Bakopulu F, Veltsista A, Vassi I, Gika A, Lekea V, Priftis K, et al. Can we look at asthma in childhood with optimism? Greek cohort study. J Asthma 2009;46:171–4.
  • 19. Bousquet J, Mantzouranis E, Cruz AA. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on severe asthma. J Allergy Clin Immunol 2010;126:926–38.
  • 20. Campo P, Rodríguez F, Sánchez-García S, Barranco P, Quirce S, Pérez-Francés C, et al. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J Investig Allergol Clin Immunol 2013;23:76-88.
  • 21. Chauhan A, Singh M, Agarwal A, Paul N. Correlation of TSLP, IL-33, and CD4 + CD25 + FOXP3 + T regulatory (Treg) in pediatric asthma. J Asthma 2015;52:868-72.
  • 22. Ying S, O'Connor B, Ratoff J, Meng Q, Fang C, Cousins D, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 2008;181:2790-98.
  • 23. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005;174:8183–90.
  • 24. Fornasa G, Tsilingiri K, Caprioli F, Botti F, Mapelli M, Meller S, et al. Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol 2015;136:413–22.
  • 25. Shikotra A, Choy DF, Ohri CM, Doran E, Butler C, Hargadon B, et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol 2012;129:104–11.e9.
  • 26. Bunyavanich S, Melen E, Wilk JB, Granada M, Soto-Quiros ME, Avila L, et al. Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy 2011;9(1).
  • 27. Harada M, Hirota T, Jodo AI, Doi S, Kameda M, Fujita K, et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2009;40:368–74.
  • 28. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673–80.
  • 29. Lee EB, Kim KW, Hong JY, Jee HM, Sohn MH, Kim KE. Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr Allergy Immunol 2010;2:457-60.
  • 30. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010;11:289-93.